Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?

Autor: Richard A. Anderson, Nicholas Hatzirodos, Raymond J. Rodgers, Katja Hummitzsch, Roseanne Rosario, Wendy M. Bonner, Nicole A Bastian, Monica Dwi Hartanti, Helen F. Irving-Rodgers, Rosemary A. L. Bayne
Rok vydání: 2020
Předmět:
0301 basic medicine
Candidate gene
endocrine system diseases
Gene Expression
Biochemistry
FSHB
Fetal Development
Database and Informatics Methods
0302 clinical medicine
Animal Cells
Pregnancy
Genes
Regulator

Medicine and Health Sciences
Connective Tissue Cells
030219 obstetrics & reproductive medicine
Multidisciplinary
Gene Expression Regulation
Developmental

Genomics
Polycystic ovary
Phenotype
Ovaries
Oncology
Connective Tissue
Androgens
Medicine
Female
Anatomy
Cellular Types
Sequence Analysis
Research Article
Polycystic Ovary Syndrome
Adult
endocrine system
Stromal cell
Genotype
Bioinformatics
medicine.drug_class
Science
Biology
Polymorphism
Single Nucleotide

Andrology
03 medical and health sciences
Extraction techniques
Genetics
Genome-Wide Association Studies
Genetic predisposition
medicine
Animals
Humans
Genetic Predisposition to Disease
Fetus
Ovary
Reproductive System
Biology and Life Sciences
Cancers and Neoplasms
Computational Biology
Human Genetics
Cell Biology
Fibroblasts
Genome Analysis
Androgen
Hormones
RNA extraction
Research and analysis methods
Biological Tissue
030104 developmental biology
Cattle
Stromal Cells
Gynecological Tumors
Sequence Alignment
Biomarkers
Genome-Wide Association Study
Zdroj: Hartanti, M D, Rosario, R, Hummitzsch, K, Bastian, N A, Hatzirodos, N, Bonner, W, Bayne, R A, Irving-Rodgers, H F, Anderson, R & Rodgers, R J 2020, ' Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life? ', PLoS ONE . https://doi.org/10.1371/journal.pone.0229351
PLoS ONE, Vol 15, Iss 2, p e0229351 (2020)
PLoS ONE
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0229351
Popis: Polycystic ovary syndrome (PCOS) affects around 10% of young women, with adverse consequences on fertility and cardiometabolic outcomes. PCOS appears to result from a genetic predisposition interacting with developmental events during fetal or perinatal life. We hypothesised that PCOS candidate genes might be expressed in the fetal ovary when the stroma develops; mechanistically linking the genetics, fetal origins and adult ovarian phenotype of PCOS. In bovine fetal ovaries (n = 37) of 18 PCOS candidate genes only SUMO1P1 was not expressed. Three patterns of expression were observed: early gestation (FBN3, GATA4, HMGA2, TOX3, DENND1A, LHCGR and FSHB), late gestation (INSR, FSHR, and LHCGR) and throughout gestation (THADA, ERBB4, RAD50, C8H9orf3, YAP1, RAB5B, SUOX and KRR1). A splice variant of FSHB exon 3 was also detected early in the bovine ovaries, but exon 2 was not detected. Three other genes, likely to be related to the PCOS aetiology (AMH, AR and TGFB1I1), were also expressed late in gestation. Significantly within each of the three gene groups, the mRNA levels of many genes were highly correlated with each other, despite, in some instances, being expressed in different cell types. TGFβ is a well-known stimulator of stromal cell replication and collagen synthesis and TGFβ treatment of cultured fetal ovarian stromal cells inhibited the expression of INSR, AR, C8H9orf3 and RAD50 and stimulated the expression of TGFB1I1. In human ovaries (n = 15, < 150 days gestation) many of the same genes as in bovine (FBN3, GATA4, HMGA2, FSHR, DENND1A and LHCGR but not TOX3 or FSHB) were expressed and correlated with each other. With so many relationships between PCOS candidate genes during development of the fetal ovary, including TGFβ and androgen signalling, we suggest that future studies should determine if perturbations of these genes in the fetal ovary can lead to PCOS in later life.
Databáze: OpenAIRE